Buy KPV 10 mg

€33.78

KPV, 10 mg, is a synthetic Lys-Pro-Val tripeptide for analytical and in vitro laboratory research. Pharma Research .eu provides documented European supply subject to lot-specific purity, identity, net-content and salt-form verification.

Category:
Description

Buy KPV, 10 mg, for Advanced Laboratory Research in Europe

KPV is a synthetic linear tripeptide comprising lysine, proline and valine, commonly written H-Lys-Pro-Val-OH. It corresponds to the C-terminal tripeptide fragment of α-melanocyte-stimulating hormone and is supplied as a laboratory reagent for peptide analytics, biochemical method development and controlled in vitro investigations. The commonly reported formula is C₁₆H₃₀N₄O₄, with average molecular mass approximately 342.43 Da. Pharma Research .eu presents this 10 mg format for qualified European laboratory teams.peptidebiologix+1

Uncompromising Purity and Analytical Characterisation

KPV should be specified as the linear tripeptide:

H-Lys-Pro-Val-OH

The free N-terminus and free C-terminal carboxylic acid should be stated explicitly. Acetylated, amidated, phosphorylated or salt-form variants may have different molecular masses, charge states and chromatographic behaviour and should not be presented as equivalent without documentation.

For laboratory procurement, the suitable target is ≥99.0% purity by RP-HPLC, subject to confirmation by the actual batch-specific certificate of analysis. Available lot reports show that KPV products can be reported above 99% HPLC purity, but these results are batch-specific and should not be transferred automatically between suppliers or lots.purelypeptides+1

A complete CoA should include:

  • RP-HPLC purity percentage, method and chromatogram.

  • LC-MS, ESI-MS or LC-MS/MS identity confirmation.

  • Peptide sequence and terminal-group designation.

  • Free-peptide, acetate or other salt-form information.

  • Molecular formula and molecular-mass assignment.

  • Net peptide content, separated from vial overfill or total residue.

  • Visual appearance of the lyophilised material.

  • Residual-solvent results from synthesis and purification.

  • Water or residual-moisture content, where measured.

  • Heavy-metal or elemental-impurity results where included in the quality programme.

  • Lot number, manufacture date, retest date and storage requirements.

The commonly reported formula is C₁₆H₃₀N₄O₄, with average molecular mass approximately 342.43 g/mol and exact mass near 342.2267 Da. Public and commercial records show conflicting CAS numbers, including 67727-97-3 and 64790-08-5. The supplier must therefore verify the correct registry record for the exact stereochemical and salt form supplied.aminopeptides.co+1

KPV is generally supplied as a white to off-white lyophilised powder. Visual inspection can identify gross discolouration, vial damage or visible contamination, but cannot establish identity or purity. Analytical release should combine appearance assessment with RP-HPLC and mass-spectral confirmation.

High purity is important because small peptides may contain deletion sequences, altered terminal groups, residual synthesis materials, counter-ions and moisture. These factors can affect retention time, ionisation efficiency, recovery and calculated concentration. A nominal “10 mg” vial may also contain overfill, so the CoA should distinguish labelled quantity from measured net peptide content. Some publicly available CoAs report content above the nominal label amount, demonstrating why net-content data should be presented carefully.purelypeptides+2

Principal Laboratory Applications and Research Methodologies

KPV is suitable for controlled laboratory research involving small-peptide chemistry, analytical characterisation and in vitro biochemical model development. All applications should be conducted by qualified personnel within an appropriately governed university, CRO, pharmaceutical R&D or analytical laboratory.

RP-HPLC and LC-MS method development. KPV can serve as a defined low-molecular-weight peptide analyte for retention-time assignment, chromatographic optimisation and intact-mass confirmation. Its ionic functional groups may require optimisation of mobile-phase pH, ionic strength and column chemistry.

Reference and system-suitability work. A characterised lot may support instrument checks, calibration development, sample-recovery studies and retention-time comparison. Unless formally certified under a recognised reference-material standard, it should be described as a research reference material or analytical reagent rather than a certified reference material.

Peptide stability and degradation research. Laboratories may investigate the influence of pH, temperature, light, oxidation, moisture and container material. Stability methods should distinguish chemical degradation from adsorption, incomplete dissolution, matrix effects and instrument carryover.

In vitro biochemical and cellular models. A verified KPV lot may be incorporated into controlled cell-free or cellular systems examining peptide-associated biochemical responses. Experimental designs should include vehicle controls, blank matrices, concentration confirmation and assessment of any effects arising from the selected solvent.

The 10 mg nominal quantity corresponds to approximately 29.2 µmol using the reported average molecular mass of 342.43 g/mol. If a CoA reports a different net content, the molar quantity should be recalculated using that measured amount and the correct salt form. No working concentration should be stated without a specified final volume and validated preparation method.

Compound Stability, Optimal Storage, and Safe Handling Protocols

KPV should remain sealed in its lyophilised state until required for a validated laboratory procedure. Research handling references commonly recommend storing the dry material at approximately −20°C, protected from light and moisture. Prepared solutions require separate stability verification because pH, container material, concentration and storage history can influence recovery.nexyralab+1

Recommended controls include:

  • Store unopened lyophilised KPV at approximately −20°C unless the CoA specifies otherwise.

  • Keep the container tightly closed, dry and protected from direct light.

  • Allow a sealed vial to reach room temperature before opening to minimise condensation.

  • Use low-binding tubes where adsorption could affect recovery.

  • Prepare aliquots if repeated access is expected.

  • Store short-term aqueous solutions at 2–8°C only where validated.

  • Use frozen aliquots for longer-term solution storage when supported by stability data.

  • Avoid repeated freeze–thaw cycles.

  • Record solvent, concentration, preparation date, operator and storage history.

The small molecular size of KPV does not guarantee unlimited solution stability. Apparent loss may arise from adsorption, pH-dependent changes, incomplete dissolution or sample-preparation effects rather than chemical degradation. HPLC or LC-MS should be used to confirm integrity after storage.

If the product is supplied as a dry peptide, reconstitution should be performed using a validated laboratory procedure. Add the selected solvent gradually, allow the powder to hydrate and mix gently. Avoid vigorous agitation unless demonstrated to be compatible with the analytical method.

Handling should follow the current SDS and institutional chemical-risk assessment. Appropriate precautions generally include a certified fume hood or suitable local containment, nitrile gloves, safety goggles and a laboratory coat. Avoid aerosol generation and direct contact with the powder or solution. Dispose of contaminated materials through approved institutional chemical and laboratory-waste procedures.

Technical Specifications and Molecular Attributes

Attribute Specification
Product KPV, 10 mg
Common designation KPV; Lys-Pro-Val; α-MSH(11–13) fragment
Sequence H-Lys-Pro-Val-OH
Residue count 3 amino acids
IUPAC name Full systematic peptide name should be confirmed on the CoA; sequence notation is preferred for procurement
CAS Registry Number Verify the exact registry number for the supplied form; 67727-97-3 and 64790-08-5 are both reported in commercial records
Molecular formula C₁₆H₃₀N₄O₄
Average molecular mass Approximately 342.43 g/mol
Exact mass Approximately 342.2267 Da
Physical state and colour Lyophilised white to off-white powder
Solubility profile Aqueous reconstitution may be feasible; solvent and buffer compatibility require assay-specific validation
Typical purity Proposed target ≥99.0% by RP-HPLC; verify the actual lot-specific result
Identity testing LC-MS, ESI-MS or LC-MS/MS
Long-term storage Typically −20°C, sealed and protected from light and moisture

The formula, sequence and molecular mass are consistent across several specifications, but CAS records and net-content values vary between suppliers. The batch CoA should control the final product page.aminopeptides.co+3

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu can position KPV as a documented European laboratory reagent for analytical chemists, biochemists and laboratory managers requiring a defined tripeptide. The product file should include a batch-specific CoA, SDS, sequence designation, purity result, identity data, terminal-group and salt-form information, measured net content and storage instructions.

Any claim that Pharma Research .eu operates an ISO 9001-certified quality-management system should be supported by a current certificate identifying the issuing body, scope and validity. Claims concerning discreet or temperature-controlled logistics across EU member states should likewise be verified for the destination, carrier route, packaging and applicable transport requirements.

A quality-focused supplier should be able to discuss:

  • KPV’s Lys-Pro-Val sequence and terminal groups.

  • Free-peptide versus salt form.

  • The correct CAS record for the supplied material.

  • RP-HPLC purity and LC-MS identity testing.

  • Measured net content versus nominal fill.

  • Residual solvents, moisture and elemental-impurity reporting.

  • Packaging configuration and container-closure integrity.

  • Storage, transport and documentation requirements.

Pharma Research .eu should therefore be described as a potential European source for research-grade KPV, with vendor-specific certification and logistics claims verified through current records. The material is intended strictly for controlled laboratory research and analytical use by qualified personnel under applicable institutional procedures.

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy KPV 10 mg”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.